SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-02
👔
Jazz Pharmaceuticals plc
@JAZZ_InsiderForm 4 Filing: COZADD BRUCE C Sells $1.8M of $JAZZ
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Jazz Pharmaceuticals plc
Ticker: $JAZZ
Transaction Value
$1.8M
Price/Share: $248.66
transaction date
2026-09-01
Shares: 7,219
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, COZADD BRUCE C, holds the title of Director at Jazz Pharmaceuticals plc.
On 2026-09-01, the insider transacted 7,219 shares.The shares were transacted at a weighted average price of $248.66 per share, resulting in a total market-relevant value of $1.8M.
Executive Summary Summary
COZADD BRUCE C (Director) sold $1.8M of $JAZZ
Post-Transaction Position: 351,875 shares
SEC Accession No: 0001193210-26-000025 (CIK: 1193210)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.